Targeted Dual Intervention-Oriented Drug-Encapsulated (DIODE) Nanoformulations for Improved Treatment of Pancreatic Cancer

Despite recent advancements, effective treatment for pancreatic ductal adenocarcinoma (PDAC) has remained elusive. The overall survival rate in PDAC patients has been dismally low due to resistance to standard therapies. In fact, the failure of monotherapies to provide long-term survival benefits in...

Descripción completa

Detalles Bibliográficos
Autores principales: Madamsetty, Vijay Sagar, Pal, Krishnendu, Dutta, Shamit Kumar, Wang, Enfeng, Mukhopadhyay, Debabrata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281578/
https://www.ncbi.nlm.nih.gov/pubmed/32397114
http://dx.doi.org/10.3390/cancers12051189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281578/
https://www.ncbi.nlm.nih.gov/pubmed/32397114
http://dx.doi.org/10.3390/cancers12051189

Ejemplares similares